.png?width=700&name=New-ATE-Logo2019%20(1).png)
The Use of Retrovirus-Like Particles (RVLP)
to Evaluate Viral Clearance in
Downstream Processing
Presenter:
David Cetlin
Senior Director, MockV Products,
Senior Director, MockV Products,
Cygnus Technologies
David Cetlin is senior director, MockV Products, at Cygnus Technologies and the founder and CEO of MockV Solutions, Inc., a company acquired by Cygnus that commercialized a novel series of BSL-1 viral clearance prediction kits. Prior to MockV, David was a purification scientist at Human Genome Sciences, specializing in viral clearance and nanofiltration.
